BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30472204)

  • 21. E2F, HSF2, and miR-26 in thyroid carcinoma: bioinformatic analysis of RNA-sequencing data.
    Lu JC; Zhang YP
    Genet Mol Res; 2016 Mar; 15(1):15017576. PubMed ID: 26985959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis.
    Yu J; Mai W; Cui Y; Kong L
    J Endocrinol Invest; 2016 Nov; 39(11):1285-1293. PubMed ID: 27250077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of hub genes in papillary thyroid carcinoma: robust rank aggregation and weighted gene co-expression network analysis.
    Liu Y; Chen TY; Yang ZY; Fang W; Wu Q; Zhang C
    J Transl Med; 2020 Apr; 18(1):170. PubMed ID: 32299435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncovering the pathogenesis of obesity complicated with papillary thyroid carcinoma via bioinformatics and experimental validation.
    Yuan K; Hu D; Mo X; Zeng R; Wu B; Zhang Z; Hu R; Wang C
    Aging (Albany NY); 2023 Sep; 15(17):8729-8743. PubMed ID: 37671970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying key genes of classic papillary thyroid cancer in women aged more than 55 years old using bioinformatics analysis.
    Li CC; Ullah MHE; Lin X; Shan SK; Guo B; Zheng MH; Wang Y; Li F; Yuan LQ
    Front Endocrinol (Lausanne); 2022; 13():948285. PubMed ID: 36120433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma.
    Xia F; Jiang B; Chen Y; Du X; Peng Y; Wang W; Wang Z; Li X
    Medicine (Baltimore); 2018 Dec; 97(51):e13802. PubMed ID: 30572540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of differentially expressed genes and signaling pathways in papillary thyroid cancer: a study based on integrated microarray and bioinformatics analysis.
    Sun T; Guan Q; Wang Y; Qian K; Sun W; Ji Q; Wu Y; Guo K; Xiang J
    Gland Surg; 2021 Feb; 10(2):629-644. PubMed ID: 33708546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the mechanisms of papillary thyroid carcinoma using transcriptome analysis.
    Qiu J; Zhang W; Xia Q; Liu F; Zhao S; Zhang K; Chen M; Zang C; Ge R; Liang D; Sun Y
    Mol Med Rep; 2017 Nov; 16(5):5954-5964. PubMed ID: 28849102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of the Potential Biomarkers of Papillary Thyroid Cancer (PTC) Based on RT
    Peng Y; Zhang HW; Cao WH; Mao Y; Cheng RC
    Cancer Manag Res; 2020; 12():9235-9246. PubMed ID: 33061614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis.
    Chen W; Liu Q; Lv Y; Xu D; Chen W; Yu J
    World J Surg Oncol; 2017 Jul; 15(1):119. PubMed ID: 28673327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated bioinformatics analysis and screening of hub genes in papillary thyroid carcinoma.
    Fan R; Dong L; Li P; Wang X; Chen X
    PLoS One; 2021; 16(6):e0251962. PubMed ID: 34115774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
    Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
    Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploration of DNA Methylation-Driven Genes in Papillary Thyroid Carcinoma Based on the Cancer Genome Atlas.
    Chen Y; Wang K; Shang M; Zhao S; Zhang Z; Yang H; Chen Z; Du R; Wang Q; Chen B
    J Comput Biol; 2021 Jan; 28(1):99-114. PubMed ID: 32790501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network Analyses of Integrated Differentially Expressed Genes in Papillary Thyroid Carcinoma to Identify Characteristic Genes.
    Shang J; Ding Q; Yuan S; Liu JX; Li F; Zhang H
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30646607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative Analysis of Potential Biomarkers Involved in the Progression of Papillary Thyroid Cancer.
    Bansal R; Saxena U
    Appl Biochem Biotechnol; 2023 May; 195(5):2917-2932. PubMed ID: 36445679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.